Tumor cell response to bevacizumab single agent therapy in vitro

Overview of attention for article published in Cancer Cell International, September 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 73 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHOD AND COMPOSITIONS FOR TUMORIGENESIS INHIBITION

Application WO-2023223022-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.